GlassScriptPhysician profile
Carrie C Herman
NPI 1023467313
$1,335.38
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $337 · 2023: $534 · 2024: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $295.51 | 2023 | Kyphon Express II Kyphopak Tray |
| Biohaven Pharmaceuticals, INC. | $207.54 | 2021 | |
| Depuy Synthes Sales INC. | $138.48 | 2022 | |
| Amgen INC. | $104.42 | 2024 | Otezla |
| Intrinsic Therapeutics | $104.15 | 2022-2023 | Barricaid Acd (Annular Closure Device) |
| Mannkind Corporation | $100.02 | 2023 | V-Go |
| Janssen Pharmaceuticals, INC | $85.61 | 2021-2022 | |
| Abbott Laboratories | $75.49 | 2023 | Proclaim |
| Melinta Therapeutics, LLC | $40.30 | 2021-2022 | |
| Medacta USA, INC. | $37.26 | 2024 | |
| Abbvie INC. | $27.27 | 2021-2022 | |
| Zimvie INC. | $22.92 | 2023 | |
| Tactile Systems Technology INC | $22.50 | 2022 | |
| Boston Scientific Corporation | $17.26 | 2022 | |
| Smith+Nephew, INC. | $16.22 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $14.48 | 2023 | Excelsiusgps Robotic Navigation System |
| Novo Nordisk INC | $14.27 | 2021 | |
| Nestle Healthcare Nutrition INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.